Article • surgical-robots
Stryker Launches Mako RPS Handheld Robotic Knee Surgery System
Stryker has officially launched Mako RPS, a robotic handheld system designed for total knee replacement procedures, expanding its orthopaedic surgical robotics portfolio and bringing advanced automated assistance to more surgeons globally.
Mako RPS represents an evolutionary advancement in orthopaedic robotics by offering a handheld solution that integrates seamlessly into standard surgical workflows while providing surgeons with enhanced physical control and intraoperative precision during total knee replacements.
For hospitals and ambulatory surgery centers that previously hesitated on full-room robotic installations due to physical constraints or capital costs, a handheld device tied to familiar power tools and the Triathlon Total Knee System offers a compelling operational fit.
The system extends Stryker's robotics reach beyond large, fixed robotic arms into versatile handheld instruments that fit directly into existing operating room setups, broadening technology adoption among surgical teams previously avoiding full-suite robotics.
Mako RPS links to Stryker's Q Guidance System, strengthening the company's broader digital technology ecosystem across orthopaedic care and driving long-term customer engagement, software usage, and recurring implant revenue across global markets.
Stryker, traded on the NYSE as SYK, has seen its stock price increase following the product announcement, drawing significant interest from financial analysts and healthcare investors tracking growth across surgical robotics markets.
The expansion of the Mako portfolio with a handheld option may alter how healthcare providers evaluate robotic-assisted knee replacement adoption while influencing competitive positioning against major orthopaedic peers over time.
As adoption of handheld surgical tools increases across ambulatory surgery centers, Stryker plans to track surgeon feedback, facility utilization trends, and procedural performance to evaluate long-term market expansion across orthopaedics.
